1 – 247 of 247
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cardiovascular disease risk in early rheumatoid arthritis : the impact of cartilage oligomeric matrix protein (COMP) and disease activity
(
- Contribution to journal › Article
-
Mark
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
(
- Contribution to journal › Article
- 2022
-
Mark
VEXAS : Medicinhistorisk kommentar apropå inslaget "UR VARDAGEN" i Reumabulletinen 151, 1/2022
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2021
-
Mark
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy : A Swedish Nationwide Register Study
(
- Contribution to journal › Article
- 2020
-
Mark
Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
(
- Contribution to journal › Article
-
Mark
Reumatologi? Nej tack, men man kan ju ändra sig!
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Apolipoprotein E triggers complement activation in joint synovial fluid of rheumatoid arthritis patients by binding C1q
(
- Contribution to journal › Article
- 2019
-
Mark
Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
(
- Contribution to journal › Article
- 2017
-
Mark
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
(
- Contribution to journal › Article
-
Mark
Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies
(
- Contribution to journal › Article
-
Mark
Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays
(
- Contribution to journal › Article
-
Mark
Indelning av de reumatiska sjukdomarna
2017) p.41-47(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Differentialdiagnostik vid ledsymtom
2017) p.91-97(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vad är reumatologi?
2017) p.21-24(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
(
- Contribution to journal › Article
-
Mark
Activation of complement by pigment epithelium-derived factor in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Immune response to pneumococcal conjugate vaccine in patients with systemic vasculitis receiving standard of care therapy
(
- Contribution to journal › Article
- 2016
-
Mark
Diet induced arthritis in pigs: Comment on the Article by Scher et al.
(
- Contribution to journal › Letter
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
-
Mark
Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective
(
- Contribution to journal › Article
-
Mark
Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal : A Prospective Observational Cohort Study from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Universitetsenheterna i reumatologi i Lund och Malmö : Historia med Ido
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Limited impact of fibromodulin deficiency on the development of experimental skin fibrosis
2016) In Experimental Dermatology(
- Contribution to journal › Article
-
Mark
Metotrexat - Cellgiftet som blev basterapi vid reumatoid artrit
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis
(
- Contribution to journal › Article
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article
- 2015
-
Mark
Cartilage oligomeric matrix protein: a new promising biomarker of liver fibrosis in chronic hepatitis C
(
- Contribution to journal › Article
-
Mark
Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years - relation to disease activity, joint damage and comorbidity.
(
- Contribution to journal › Article
-
Mark
The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
(
- Contribution to journal › Article
-
Mark
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
(
- Contribution to journal › Article
-
Mark
Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
(
- Contribution to journal › Article
-
Mark
Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab.
(
- Contribution to journal › Letter
- 2014
-
Mark
Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.
(
- Contribution to journal › Article
-
Mark
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
(
- Contribution to journal › Article
-
Mark
Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort
(
- Contribution to journal › Article
-
Mark
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Novel COMP Neoepitopes Identified in Synovial Fluids from Patients with Joint Diseases using Affinity Chromatography and Mass Spectrometry.
(
- Contribution to journal › Article
-
Mark
Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis - a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjogren's syndrome and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Articular cartilage
2014) p.33-41(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Relationships amongst osteoarthritis biomarkers, dynamic knee joint load, and exercise: results from a randomized controlled pilot study
(
- Contribution to journal › Article
-
Mark
Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs
(
- Contribution to journal › Article
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article
-
Mark
Reumatologisk forskning i Lund/Malmö
(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Tema: Ledord. Ortopedi. Reumatologi. Förord
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
(
- Contribution to journal › Article
- 2012
-
Mark
Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts
(
- Contribution to journal › Letter
-
Mark
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment
(
- Contribution to journal › Article
-
Mark
Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases.
(
- Contribution to journal › Article
-
Mark
Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study
(
- Contribution to journal › Article
-
Mark
PRELP Protein Inhibits the Formation of the Complement Membrane Attack Complex
(
- Contribution to journal › Article
-
Mark
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade .
(
- Contribution to journal › Article
-
Mark
Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
(
- Contribution to journal › Article
-
Mark
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis.
(
- Contribution to journal › Article
- 2011
-
Mark
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
(
- Contribution to journal › Article
-
Mark
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
(
- Contribution to journal › Article
-
Mark
S100A8/A9 in bleomycin-induced skin fibrosis
2011) 31st European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 70(Suppl. 2).(
- Contribution to journal › Published meeting abstract
-
Mark
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
(
- Contribution to journal › Article
-
Mark
Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
(
- Contribution to journal › Article
-
Mark
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials.
(
- Contribution to journal › Article
-
Mark
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Ten years with biologics: to whom do data on effectiveness and safety apply?
(
- Contribution to journal › Article
-
Mark
Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
The role of the cartilage matrix in osteoarthritis.
(
- Contribution to journal › Article
-
Mark
National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Differentialdiagnostik vid ledsymtom
2011) p.39-44(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Vad är reumatologi?
2011) p.15-17(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2010
-
Mark
Inflammation and joint disease: Molecules/fragments that are released upon cartilage breakdown can activate complement and provide a new diagnostics for pathological complement activation
(
- Contribution to journal › Published meeting abstract
-
Mark
Utility-based outcomes made easy: The number needed per QALY gained (NNQ). Observational cohort study from Southern Sweden of TNF blockade in inflammatory arthritis.
(
- Contribution to journal › Article
-
Mark
Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training
(
- Contribution to journal › Article
-
Mark
Regulation of complement by COMP allows for a novel molecular diagnostic principle in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
(
- Contribution to journal › Article
-
Mark
Presence of peripheral arthritis and male sex predicting continuation of anti–tumor necrosis factor therapy in ankylosing spondylitis: An observational prospective cohort study from the South Swedish arthritis treatment group register
(
- Contribution to journal › Article
- 2009
-
Mark
Association of Biomarkers With Pre-Radiographically Defined and Radiographically Defined Knee Osteoarthritis in a Population-Based Study
(
- Contribution to journal › Article
-
Mark
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
(
- Contribution to journal › Article
-
Mark
Natural course of knee osteoarthritis in middle-aged subjects with knee pain: 12-year follow-up using clinical and radiographic criteria
(
- Contribution to journal › Article
-
Mark
Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents
(
- Contribution to journal › Article
-
Mark
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register.
(
- Contribution to journal › Article
-
Mark
Differences in Longitudinal Disease and Treatment Characteristics of Patients with Rheumatoid Arthritis Replying and Not Replying to a Postal Questionnaire. Experience from a Biologics Register in Southern Sweden.
(
- Contribution to journal › Article
-
Mark
Bone mineral density in the hand as a predictor for mortality in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
(
- Contribution to journal › Article
- 2008
-
Mark
Increased serum levels of cartilage oligomeric matrix protein precede the clinical onset of rheumatoid arthritis despite lower levels among smokers
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.289-290(
- Contribution to journal › Published meeting abstract
-
Mark
Health utilities improvement during TNF blockade in chronic arthritis occurs early in the treatment course, results from an eight year observational study in southern Sweden
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.552-552(
- Contribution to journal › Published meeting abstract
-
Mark
Citrullinated proteins are present in synovial fluids from inflammatory arthritis but not osteoarthritis
(
- Contribution to journal › Published meeting abstract
-
Mark
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis
(
- Contribution to journal › Article
-
Mark
Biomarkers in the prediction of radiographic progression in early rheumatoid arthritis: comment on the article by Young-Min et al - Reply
(
- Contribution to journal › Letter
-
Mark
Efficacy and tolerability of anti-TNF therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
COMP a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
(
- Contribution to journal › Article
-
Mark
The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice
(
- Contribution to journal › Published meeting abstract
-
Mark
Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement
(
- Contribution to journal › Article
-
Mark
Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
- 2007
-
Mark
Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab
(
- Contribution to journal › Letter
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
-
Mark
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers
(
- Contribution to journal › Article
-
Mark
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
(
- Contribution to journal › Article
-
Mark
The impact of IL-1Ra and MBL gene polymorphisms on joint damage after 5 and 10 years in patients with early rheumatoid arthritis
(
- Contribution to journal › Letter
-
Mark
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
(
- Contribution to journal › Article
-
Mark
Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper
(
- Contribution to journal › Scientific review
-
Mark
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
(
- Contribution to journal › Article
-
Mark
Behandling af reumatoid artrit med anti-tumornekrosefaktor-alpha-antistof. Individuel monitorering af biotilgaengelighed og immunogenicitet-- sekundaerpublikation
(
- Contribution to journal › Article
-
Mark
Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2006
-
Mark
The heritable determinants of cartilage oligomeric matrix protein
(
- Contribution to journal › Article
-
Mark
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
(
- Contribution to journal › Article
-
Mark
Classification of osteoarthritis biomarkers: a proposed approach
(
- Contribution to journal › Scientific review
-
Mark
Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
(
- Contribution to journal › Article
-
Mark
The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab
(
- Contribution to journal › Article
-
Mark
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis
(
- Contribution to journal › Article
-
Mark
Allvarlig lungsjukdom vid RA och TNF-blockering--finns det ett samband?
(
- Contribution to journal › Article
-
Mark
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Non-collagenous Proteins; Glycoproteins and related proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Biomarkers for cartilage and bone in rheumatoid arthritis
2006) p.301-301(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Noncollagenous Proteins: Glycoproteins and Related Proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Glukosamin hjälper inte mot smärta vid knäartros
(
- Contribution to journal › Letter
- 2005
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Prediction of mortality in rheumatoid arthritis based on disease activity markers.
(
- Contribution to journal › Article
-
Mark
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
(
- Contribution to journal › Article
-
Mark
No increase of severe infections in RA patients treated with TNF-blockers
2005) Annual European Congress of Rheumatology, 2005 In Annals of the Rheumatic Diseases 64(Suppl. 3). p.461-462(
- Contribution to journal › Published meeting abstract
-
Mark
Changes of cartilage and bone markers after intraarticular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales
(
- Contribution to journal › Letter
-
Mark
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
(
- Contribution to journal › Article
-
Mark
Prognostic laboratory markers of joint damage in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article
-
Mark
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis
(
- Contribution to journal › Article
-
Mark
Response criteria for rheumatoid arthritis in clinical practice - how useful are they?
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2004
-
Mark
Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures.
(
- Contribution to journal › Article
-
Mark
Hormone replacement therapy, calcium and vitamin D-3 versus calcium and vitamin D-3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
(
- Contribution to journal › Article
-
Mark
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al
(
- Contribution to journal › Letter
-
Mark
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP
(
- Contribution to journal › Article
- 2003
-
Mark
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept.
(
- Contribution to journal › Article
-
Mark
Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Recent developments and future research in the bone and joint decade 2000-2010.
(
- Contribution to journal › Letter
-
Mark
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.
(
- Contribution to journal › Article
-
Mark
Cyclosporin A in rheumatoid arthritis
(
- Contribution to journal › Letter
-
Mark
Inflammation is a feature of the disease process in early knee joint osteoarthritis.
(
- Contribution to journal › Letter
-
Mark
Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.
(
- Contribution to journal › Article
- 2002
-
Mark
Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.
(
- Contribution to journal › Article
-
Mark
Förlegat beskriva artros som "degenerativ ledsjukdom"
(
- Contribution to journal › Letter
-
Mark
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
(
- Contribution to journal › Article
-
Mark
Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae.
(
- Contribution to journal › Article
-
Mark
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.
(
- Contribution to journal › Article
-
Mark
Markers of joint tissue turnover in osteoarthritis
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Behandling med TNF-hämmare vid reumatoid artrit
(
- Contribution to journal › Article
-
Mark
Markers of joint tissue turnover in osteoarthritis
2002) p.285-292(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2001
-
Mark
Association of chondroadherin with collagen type II
(
- Contribution to journal › Article
-
Mark
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Cytokines, metalloproteinase, their inhibitors, and COMP: relation to radiological progression and inflammation in early rheumatoid arthritis
(
- Contribution to journal › Article
- 2000
-
Mark
Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Genetic control of arthritis in rats
(
- Contribution to journal › Article
-
Mark
Diagnosis of osteoarthritis in relation to molecular processes in cartilage: comment on the article by Clark et al.
(
- Contribution to journal › Article
-
Mark
Molecular markers for assessment of cartilage damage in rheumatoid arthritis
2000) p.291-304(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis
(
- Contribution to journal › Article
-
Mark
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relations to pulmonary involvement
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Nya läkemedel mot reumatoid artrit : Förbättrade behandlingsmöjligheter ställer nya krav på sjukvårdsorganisationen
(
- Contribution to journal › Article
- 1999
-
Mark
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with osteoarthritis-related type II collagen gene COL2A1 mutation
(
- Contribution to journal › Article
-
Mark
Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis
(
- Contribution to journal › Article
-
Mark
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978
(
- Contribution to journal › Article
-
Mark
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
(
- Contribution to journal › Article
-
Mark
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
(
- Contribution to journal › Article
- 1998
-
Mark
Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint
(
- Contribution to journal › Article
-
Mark
Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
(
- Contribution to journal › Article
-
Mark
Joint space width in the axial view of the patello-femoral joint: Definitions and comparisons with MR imaging
(
- Contribution to journal › Article
-
Mark
Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats
(
- Contribution to journal › Article
-
Mark
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study.
(
- Contribution to journal › Article
-
Mark
Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats
(
- Contribution to journal › Article
- 1997
-
Mark
Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction
(
- Contribution to journal › Article
-
Mark
Cartilage markers in synovial fluid in symptomatic knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Serum biological markers as predictors of disease progression in osteoarthritis of the knee
(
- Contribution to journal › Letter
-
Mark
HLA DRB1* typing and cartilage oligomeric matrix protein as predictors of joint destruction in recent onset rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic knee pain.
(
- Contribution to journal › Article
-
Mark
Cartilage matrix macromolecules in joint fluid of temporomandibular joints before and six months after diskectomy
(
- Contribution to journal › Article
-
Mark
Cartilage macromolecules and the development of new methods for the assessment of joint disease
(
- Contribution to journal › Article
-
Mark
Serum analyses of tissue derived macromolecules and markers of inflammation in early rheumatoid arthritis. Relation to development of joint destructions in hands and feet
(
- Contribution to journal › Article
-
Mark
Postero-anterior radiogram of the knee in weightbearing and semiflexion. Comparison with MR imaging
(
- Contribution to journal › Article
-
Mark
Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis
(
- Contribution to journal › Article
-
Mark
Cartilage macromolecules in knee synovial fluid. Markers of the disease course in patients with acute oligoarthritis
(
- Contribution to journal › Article
- 1996
-
Mark
Increased concentrations of bone sialoprotein in joint fluid after knee injury
(
- Contribution to journal › Article
-
Mark
Pristance-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by MHC and non-MHC genes
(
- Contribution to journal › Article
- 1995
-
Mark
Authors' reply
(
- Contribution to journal › Article
-
Mark
Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Cartilage and bone metabolism in rheumatoid arthritis: Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism
(
- Contribution to journal › Article
-
Mark
Serum concentrations of two cartilage matrix proteins reflecting different aspects of cartilage turnover in relapsing polychondritis
(
- Contribution to journal › Article
-
Mark
Matrix proteins: Potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis
(
- Contribution to journal › Article
-
Mark
Relationship between serum cartilage oligomeric matrix protein levels and disease progression on osteoarthritis of the knee joint.
(
- Contribution to journal › Article
-
Mark
Differential release of molecular markers in joint disease
(
- Contribution to journal › Article
- 1994
-
Mark
Cartilage metabolism in the injured and uninjured knee of the same patient
(
- Contribution to journal › Article
-
Mark
Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
(
- Contribution to journal › Article
-
Mark
An extra cysteine in one of the non calcium binding EGF-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome
(
- Contribution to journal › Article
- 1993
-
Mark
Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis
(
- Contribution to journal › Article
-
Mark
Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis
(
- Contribution to journal › Article
- 1992
-
Mark
Cytidine deaminase and lactoferrin in inflammatory synovial fluids. Indicators of local polymorphonuclear cell function?
(
- Contribution to journal › Article
-
Mark
Immunologic response to collagen-impregnated vascular grafts
(
- Contribution to journal › Article
-
Mark
Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions.
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein. A novel marker of cartilage turnover detectable in synovial fluid and blood
(
- Contribution to journal › Article
-
Mark
Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Markers of cartilage destruction. In Rheumatoid Arthritis. Recent Research Advances
1992) p.348-362(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Konsekvenser av inflammation. Effekter på brosk och ben
1992)(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 1991
-
Mark
Human monocyte elastolytic activity, the propeptides of types I and III procollagen, proteoglycans and interleukin 6 in synovial fluid from patients with arthritis
(
- Contribution to journal › Article
-
Mark
Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of associaton.
(
- Contribution to journal › Article
-
Mark
Connective tissue macromolecules as markers for tissue processes in joint disease.
(
- Contribution to journal › Article
-
Mark
Molecular markers of processes in cartilage in joint disease
(
- Contribution to journal › Article
-
Mark
Macromolecular markers in joint disease
(
- Contribution to journal › Article
- 1990
-
Mark
Immune response to collagen impregnated Dacron double velour grafts for aortic and aorto-femoral reconstructions
(
- Contribution to journal › Article
-
Mark
Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release
(
- Contribution to journal › Article
- 1989
-
Mark
Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints
(
- Contribution to journal › Article
-
Mark
Involvement of nonarticular cartilage, as demonstrated by release of a cartilage-specific protein, in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Cartilage derived proteoglycans in body fluids of children. Inverse correlation with age.
(
- Contribution to journal › Article
-
Mark
Molecular markers for joint disease.
1989) p.223-228(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Bestämning av matrixkomponenter i ledvätska och blod – ett nytt sätt att studera broskpåverkan vid ledsjukdom.
(
- Contribution to journal › Article
- 1988
-
Mark
Measurement of synovial fluid volume using albumin dilution upon intraarticular saline injection
(
- Contribution to journal › Article
-
Mark
Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage.
(
- Contribution to journal › Article
-
Mark
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.
(
- Contribution to journal › Article
-
Mark
The aminoterminal-type-III procollagen pepetide and proteoglycans in serum and synovial fluid in patients with rheumatoid arthritis or reactive arthritis.
(
- Contribution to journal › Article
-
Mark
Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.
(
- Contribution to journal › Article
- 1987
-
Mark
Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.
(
- Contribution to journal › Article
-
Mark
Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
(
- Contribution to journal › Article
-
Mark
Cartilage proteoglycans in degenerative joint disease.
(
- Contribution to journal › Article
- 1986
-
Mark
Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.
(
- Contribution to journal › Article
- 1985
-
Mark
Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
(
- Contribution to journal › Article
- 1984
-
Mark
Factors related to the progression of joint destruction in rheumatoid arthritis.
(
- Contribution to journal › Article
- 1982
-
Mark
Preleukemic syndrome simulating SLE
(
- Contribution to journal › Article
- 1980
-
Mark
Plasma levels of beta-2 microglobulin in rheumatoid arthritis.
(
- Contribution to journal › Article